Camila Odio is an Infectious Disease physician affiliated with National Institutes of Health. OpenAlex indexes 50 publications with 8,859 citations (h-index 18); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Center Dr Rm 12c103
Bethesda, MD 208923220
Telephone
240-338-4945Provider last certified this registry record 23 Dec 2023.
Clinical trials
- Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
Sponsor: National Institutes of Health Clinical Center (CC)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.4%ACE inhibitor55.4%Lisinopril100%Part D≥11 patientsStatin25%Atorvastatin Calcium100%Part D<11 patientsRespiratory
19.6%Corticosteroid19.6%Flovent Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”